Fox 19: Swallowing and COVID-19
UC expert in voice, swallow and airway discusses COVID-19 challenges
Who doesn’t go through a day without swallowing?
One in 25 adults in the United States suffer from dysphagia: the medical term for swallowing disorders. Swallowing problems tend to intensify with increasing age and are of particular concern for patients 65 and over in the midst of the COVID-19 era.
Severe dysphagia can lead to aspiration pneumonia, which can be a mimicker of the respiratory systems seen in COVID-19. Cough generating procedures, also called aerosol generating procedures, have been deemed high risk by the Centers for Disease Control and Prevention.
Rebecca Howell, MD, associate professor in the UC College of Medicine and UC Health physician, has worked with her colleagues to offer some solutions for treating swallowing patients in the backdrop of a pandemic. They are offering best practices in a recently published paper Moving Forward with Dysphagia Care: Implementing Strategies during the COVID-19 Pandemic and Beyond.
Listen to her interview with Fox 19 morning news on the subject.
Related Stories
'Time is brain' again, now for control of intracerebral hemorrhage
February 5, 2026
MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).
Children exposed to gambling mechanics before they understand money
February 4, 2026
Gambling-style mechanics are becoming a routine part of children’s digital lives, appearing in online games, mobile apps and even sports betting advertisements that surround popular media. University of Cincinnati experts warned in a recent WKRC-TV Local 12 report that long before children understand the value of money, they are learning the emotional highs and lows associated with risk. Online games, such as Roblox and Fortnite, offer fast-paced rewards that can keep children glued to screens.
Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage
February 4, 2026
The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.